Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis

被引:31
作者
Deepe, GS
Gibbons, R
机构
[1] Univ Cincinnati, Coll Med, Dept Med, Div Infect Dis, Cincinnati, OH 45267 USA
[2] Cincinnati Vet Affairs Hosp, Cincinnati, OH USA
关键词
D O I
10.1128/IAI.69.5.3128-3134.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously reported that immunization with H antigen from Histoplasma capsulatum did not protect mice against an intravenous challenge with yeasts, Here, we investigated the utility of H antigen to protect mice in a model of pulmonary histoplasmosis. Mice immunized with H antigen and challenged intranasally 4 weeks postvaccination were protected against sublethal and lethal challenges with H, capsulatum yeasts. If the challenge was performed 3 months after vaccination, there was a reduction in fungal burden following sublethal challenge and a modest delay in mortality in mice given a lethal inoculum, Vaccination was associated with production of gamma interferon, granulocyte-macrophage colony-stimulating factor, interleukin-4, and interleukin-10 by splenocytes. Vaccination with H antigen was not accompanied by a major expansion of CD4(+) or CD8(+) cells in spleens of mice. These results demonstrate that Il antigen may be useful as a protective immunogen against pulmonary exposure to H. capsulatum..
引用
收藏
页码:3128 / 3134
页数:7
相关论文
共 25 条
[21]   Vaccines against intracellular infections requiring cellular immunity [J].
Seder, RA ;
Hill, AVS .
NATURE, 2000, 406 (6797) :793-798
[22]   TUMOR-NECROSIS-FACTOR-ALPHA PLAYS A ROLE IN HOST DEFENSE AGAINST HISTOPLASMA-CAPSULATUM [J].
SMITH, JG ;
MAGEE, DM ;
WILLIAMS, DM ;
GRAYBILL, JR .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (06) :1349-1353
[23]   EARLY ACTIVATION OF SPLENIC MACROPHAGES BY TUMOR-NECROSIS-FACTOR-ALPHA IS IMPORTANT IN DETERMINING THE OUTCOME OF EXPERIMENTAL HISTOPLASMOSIS IN MICE [J].
WUHSIEH, BA ;
LEE, GS ;
FRANCO, M ;
HOFMAN, FM .
INFECTION AND IMMUNITY, 1992, 60 (10) :4230-4238
[24]  
ZHOU P, 1995, J IMMUNOL, V155, P785
[25]  
Zhou P, 1998, J IMMUNOL, V160, P1359